| 11/16/2026 11:00 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Autolus Therapeutics (1730463) Subject | Form SCHEDULE 13G/A | |
| 11/12/2026 5:43 AM | Autolus Therapeutics (1730463) Subject Qatar Investment Authority (1441449) Filed by | Form SCHEDULE 13G/A | |
| 11/10/2026 3:47 PM | Autolus Therapeutics (1730463) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/10/2026 6:25 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/22/2026 11:15 PM | Autolus Therapeutics (1730463) Filer | Form EFFECT | |
| 09/22/2026 3:51 PM | Autolus Therapeutics (1730463) Filer | Form 424B3 | |
| 09/15/2026 3:22 PM | Autolus Therapeutics (1730463) Filer | Form DEL AM | |
| 09/11/2026 7:48 PM | Autolus Therapeutics (1730463) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/03/2026 3:36 PM | Autolus Therapeutics (1730463) Issuer Piccina Cintia (1907199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/02/2026 2:31 PM | Autolus Therapeutics (1730463) Subject Piccina Cintia (1907199) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/28/2026 8:08 PM | Autolus Therapeutics (1730463) Subject PPF Group a.s. (1788137) Filed by | Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for AUTL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Autolus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/14/2026 9:01 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Autolus Therapeutics (1730463) Subject | Form SCHEDULE 13G/A | |
| 08/11/2026 6:33 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/03/2026 7:11 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/03/2026 6:00 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/01/2026 3:15 PM | Autolus Therapeutics (1730463) Issuer Leiderman Elisabeth (1842133) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:17 PM | Autolus Therapeutics (1730463) Issuer Richardson Ryan (2054449) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:18 PM | Autolus Therapeutics (1730463) Issuer Rao Madduri Ravin (1792006) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:21 PM | Autolus Therapeutics (1730463) Issuer YOUNG WILLIAM D (1217420) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:04 PM | Autolus Therapeutics (1730463) Issuer BONNEY MICHAEL W (1219016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 3:07 PM | Autolus Therapeutics (1730463) Issuer Azelby Robert (1656998) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/29/2026 3:03 PM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2026 6:30 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 2:04 PM | Autolus Therapeutics (1730463) Subject MAK Capital Fund LP (1426156) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 10:06 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Autolus Therapeutics (1730463) Subject | Form SCHEDULE 13G/A | |
| 05/14/2026 3:31 PM | Autolus Therapeutics (1730463) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/14/2026 6:53 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 11:15 PM | Autolus Therapeutics (1730463) Filer | Form EFFECT | |
| 05/05/2026 11:15 PM | Autolus Therapeutics (1730463) Filer | Form EFFECT | |
| 04/29/2026 4:28 PM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 9:31 AM | Autolus Therapeutics (1730463) Filer | Form DEL AM | |
| 04/14/2026 8:21 PM | Autolus Therapeutics (1730463) Filer | Form DEL AM | |
| 04/08/2026 3:17 PM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 3:39 PM | Autolus Therapeutics (1730463) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/27/2026 7:02 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/23/2026 3:54 PM | Autolus Therapeutics (1730463) Issuer Richardson Ryan (2054449) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:40 PM | Autolus Therapeutics (1730463) Issuer Piccina Cintia (1907199) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:59 PM | Autolus Therapeutics (1730463) Issuer Will Matthias (2121979) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:00 PM | Autolus Therapeutics (1730463) Issuer Leiderman Elisabeth (1842133) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:01 PM | Autolus Therapeutics (1730463) Issuer BUTITTA CYNTHIA M (1222082) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:58 PM | Autolus Therapeutics (1730463) Issuer YOUNG WILLIAM D (1217420) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
Prediction: NVDA will “snap back” on this date (Ad) Others paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access for just $7.
The specialized indicator shows when a stock is likely to "snap back," helping traders avoid buying at the peak. It can also flag when a stock may bounce off the bottom so you can time your entry.
Run NVDA or any other popular AI stock through it before you place a trade. Get lifetime access to the Snapback Indicator for just $7 today. |
| 03/18/2026 6:47 PM | Autolus Therapeutics (1730463) Issuer Swan Alexander (1976333) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:48 PM | Autolus Therapeutics (1730463) Issuer Williams Christopher Michael James (2121974) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:48 PM | Autolus Therapeutics (1730463) Issuer Vann Christopher Andrew (2121963) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:49 PM | Autolus Therapeutics (1730463) Issuer Pule Martin Anton (2121977) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:50 PM | Autolus Therapeutics (1730463) Issuer Itin Christian (1362010) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:51 PM | Autolus Therapeutics (1730463) Issuer Berriman John E (1291964) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:52 PM | Autolus Therapeutics (1730463) Issuer Iannone Robert (1737329) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:53 PM | Autolus Therapeutics (1730463) Issuer Bain Linda (1578407) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:54 PM | Autolus Therapeutics (1730463) Issuer Dolski Robert (1840408) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:55 PM | Autolus Therapeutics (1730463) Issuer McIlvenny Patrick Paul (2121503) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:55 PM | Autolus Therapeutics (1730463) Issuer BONNEY MICHAEL W (1219016) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:56 PM | Autolus Therapeutics (1730463) Issuer Rao Madduri Ravin (1792006) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:57 PM | Autolus Therapeutics (1730463) Issuer Azelby Robert (1656998) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:45 PM | Autolus Therapeutics (1730463) Issuer Neville Miranda Suzette (2122016) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:46 PM | Autolus Therapeutics (1730463) Issuer Driggs Alex (1708997) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 8:51 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Autolus Therapeutics (1730463) Subject | Form SCHEDULE 13G/A | |
| 02/13/2026 3:07 PM | Autolus Therapeutics (1730463) Subject MAK Capital Fund LP (1426156) Filed by | Form SCHEDULE 13G/A | |
| 01/26/2026 3:07 PM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/26/2026 3:09 PM | Autolus Therapeutics (1730463) Filer | Form 424B3 | |
| 01/12/2026 7:37 AM | Autolus Therapeutics (1730463) Filer | Form 424B3 | |
| 01/12/2026 7:36 AM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/02/2025 4:17 PM | Autolus Therapeutics (1730463) Filer | Form 424B3 | |
| 12/02/2025 3:49 PM | Autolus Therapeutics (1730463) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |